1150 related articles for article (PubMed ID: 34477236)
1. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
2. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
4. India's COVID-19 vaccination drive: key challenges and resolutions.
Choudhary OP; Choudhary P; Singh I
Lancet Infect Dis; 2021 Nov; 21(11):1483-1484. PubMed ID: 34529961
[No Abstract] [Full Text] [Related]
5. Individual preferences for COVID-19 vaccination in China.
Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
[TBL] [Abstract][Full Text] [Related]
6. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
MacIntyre CR; Costantino V; Trent M
Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
[TBL] [Abstract][Full Text] [Related]
7. Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas.
Sah P; Moghadas SM; Vilches TN; Shoukat A; Singer BH; Hotez PJ; Schneider EC; Galvani AP
Lancet Infect Dis; 2021 Nov; 21(11):1493-1494. PubMed ID: 34627498
[No Abstract] [Full Text] [Related]
8. Herd immunization with childhood vaccination may provide protection against COVID-19.
Yu Y
Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
[TBL] [Abstract][Full Text] [Related]
9. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
10. The long road.
Cohen J
Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
[No Abstract] [Full Text] [Related]
11. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
[TBL] [Abstract][Full Text] [Related]
12. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
Chun JY; Jeong H; Kim Y
J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
[TBL] [Abstract][Full Text] [Related]
13. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
Voigt A; Omholt S; Almaas E
PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
[TBL] [Abstract][Full Text] [Related]
14. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
Dashdorj NJ; Wirz OF; Röltgen K; Haraguchi E; Buzzanco AS; Sibai M; Wang H; Miller JA; Solis D; Sahoo MK; Arunachalam PS; Lee AS; Shah MM; Liu J; Byambabaatar S; Bat-Ulzii P; Enkhbat A; Batbold E; Zulkhuu D; Ochirsum B; Khurelsukh T; Dalantai G; Burged N; Baatarsuren U; Ariungerel N; Oidovsambuu O; Bungert AS; Genden Z; Yagaanbuyant D; Mordorj A; Pulendran B; Chinthrajah S; Nadeau KC; Jardetzky T; Wilbur JL; Wohlstadter JN; Sigal GB; Pinsky BA; Boyd SD; Dashdorj ND
Cell Host Microbe; 2021 Dec; 29(12):1738-1743.e4. PubMed ID: 34861167
[TBL] [Abstract][Full Text] [Related]
16. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
Jentsch PC; Anand M; Bauch CT
Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
18. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
20. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
